D

Dr Habeebullah Life Sciences Ltd
BSE:539267

Watchlist Manager
Dr Habeebullah Life Sciences Ltd
BSE:539267
Watchlist
Price: 19.49 INR 4.56%
Market Cap: ₹443.4m

Operating Margin

0%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
₹0
/
₹0

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
₹0
/
₹0

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Dr Habeebullah Life Sciences Ltd
BSE:539267
443.4m INR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
223.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
154.9B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
81.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.3B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
275.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
37.4B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.2B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.6B EUR
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Dr Habeebullah Life Sciences Ltd
Glance View

Dr Habeebullah Life Sciences Ltd. is an India-based company. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2015-08-10. The firm is engaged in research and development (R&D), trading, import and exports, and R&D services of bioproducts and pharma products. The firm's products and R&D include Stem Cell R&D, New Drug Discovery, ribonucleic acid (RNA) Interference, Molecular Biomarkers and Medical Devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology, stem cell and cord blood banking. Its New Drug Discovery division is focused on working on five therapeutic areas of Wilson’s disease, non-alcoholic steatohepatitis (NASH), neuropathic pain, cardiovascular diseases, cystinosis and Huntington's disease. Its services include molecular diagnostics, stem cell therapy, clinical services, contract research organization and academic services.

SAMSRITA Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Back to Top